The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPOView Video
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plantView Video

Latest Share Chat

Blocklisting - Interim Review

27 Feb 2024 07:00

The Biotech Growth Trust Plc - Blocklisting - Interim Review

The Biotech Growth Trust Plc - Blocklisting - Interim Review

PR Newswire

LONDON, United Kingdom, February 27

 

BLOCK LISTING SIX MONTHLY RETURN

 

 

 

Date: 27 February 2024

 

Name of applicant:

The Biotech Growth Trust PLC

Name of scheme:

General

Period of return:

From:

27 August 2023

To:

26 February 2024

Balance of unallotted securities under scheme(s) from previous return:

3,530,634

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

Nil

Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

Nil

Equals: Balance under scheme(s) not yet issued/allotted at end of period:

3,530,634

 

Name of contact:

Katherine Manson - Frostrow Capital LLP

Telephone number of contact:

020 3709 8734

 

 

 



Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.